ArticlePloS one2025

Targeting the cyclin D/CDK4 Axis to unlock new therapeutic approaches to enhance cancer treatment.

Ibrahim Khater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.